ASTRAZENECA PHARMA INDIA
|
The Current P/E Ratio of ASTRAZENECA PHARMA INDIA is 194.57.
Share Price | ₹6,375.5 | Dec 27,2024 |
Market Cap | ₹15,938.6 Cr | |
Earnings-TTM | ₹81.9 Cr | TTM-Standalone Results |
Price/Earnings | 194.57x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ASTRAZENECA PHARMA INDIA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹15,938.6 Cr] as on Dec 27,2024
(/) Earnings [ ₹81.9 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 194.57x ]
Thus, for ASTRAZENECA PHARMA INDIA , the investors are currently willing to pay 194.57 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ASTRAZENECA PHARMA INDIA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ASTRAZENECA PHARMA INDIA over the last five years.
Historical PE (Price/Earnings) ratio chart of ASTRAZENECA PHARMA INDIA
PE Ratio Performance Analysis for ASTRAZENECA PHARMA INDIA
- ASTRAZENECA PHARMA INDIA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 86.26x.
- ASTRAZENECA PHARMA INDIA 's operated at median p/e ratio of 82.35x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ASTRAZENECA PHARMA INDIA 's p/e ratio peaked in Mar2022 at 103.71x.
- ASTRAZENECA PHARMA INDIA 's p/e ratio hit its five-year low in Mar2021 of 80.66x.
How does ASTRAZENECA PHARMA INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ASTRAZENECA PHARMA INDIA | 81.92 | 194.57 | 15,938.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 40.11 | 446,684.0 |
CIPLA LTD | 4,485.22 | 27.12 | 121,639.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 21.44 | 115,931.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.77 | 97,876.4 |
DIVIS LABORATORIES LTD | 1,836.00 | 84.93 | 155,935.0 |
MANKIND PHARMA LTD | 2,124.86 | 55.79 | 118,539.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 63.97 | 115,269.0 |
LUPIN LTD | 2,651.94 | 38.33 | 101,649.0 |
AUROBINDO PHARMA LTD | 3,598.83 | 20.50 | 73,785.0 |
ABBOTT INDIA LTD | 1,284.66 | 48.46 | 62,260.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ASTRAZENECA PHARMA INDIA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 20.50x |
Max industry PE | 194.57x |
Median industry PE | 40.11x |
Average industry PE | 56.18x |
You may also like the below Video Courses